David Matuskey
Overview
Explore the profile of David Matuskey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
105
Citations
2149
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Omidvari N, Shanina E, Leung E, Sun X, Li Y, Mulnix T, et al.
J Nucl Med
. 2024 Dec;
66(1):150-157.
PMID: 39638433
Quantitative molecular imaging with PET can offer insights into physiologic and pathologic processes and is widely used for studying brain disorders. The NeuroEXPLORER is a recently developed dedicated brain PET...
2.
Davis M, Asch R, Weiss E, Wagner A, Fineberg S, Nabulsi N, et al.
Biol Psychiatry Cogn Neurosci Neuroimaging
. 2024 Nov;
10(3):324-332.
PMID: 39613160
Background: Borderline personality disorder (BPD) is a serious psychiatric condition that is associated with a high risk for suicide attempts (SAs) and death by suicide. However, relatively little is known...
3.
Honhar P, Sadabad F, Tinaz S, Gallezot J, Dias M, Naganawa M, et al.
Brain Commun
. 2024 Oct;
6(5):fcae345.
PMID: 39429243
[F]FE-PE2I PET is a promising alternative to single positron emission computed tomography-based dopamine transporter (DAT) imaging in Parkinson's disease. While the excellent discriminative power of [F]FE-PE2I PET has been established,...
4.
Matuskey D, Yang Y, Naganawa M, Koohsari S, Toyonaga T, Gravel P, et al.
Mol Psychiatry
. 2024 Oct;
PMID: 39367053
The neural bases of autism are poorly understood at the molecular level, but evidence from animal models, genetics, post-mortem studies, and single-gene disorders implicate synaptopathology. Here, we use positron emission...
5.
Cayir S, Tezel M, Matuskey D
J Geriatr Psychiatry Neurol
. 2024 Sep;
38(2):143-149.
PMID: 39244698
Objective: Social factors can influence the brain's dopaminergic function. This study investigated the relationship between socioenvironmental factors and dopamine transporter (DaT) availability in healthy individuals (n = 74) and those...
6.
Naganawa M, Gallezot J, Li S, Nabulsi N, Henry S, Cai Z, et al.
Eur J Nucl Med Mol Imaging
. 2024 Aug;
52(1):113-121.
PMID: 39155309
Purpose: [F]SynVesT-1, a positron emission tomography (PET) radiotracer for the synaptic vesicle glycoprotein 2A (SV2A), demonstrates kinetics similar to [C]UCB-J, with high brain uptake, fast kinetics fitting well with the...
7.
Li H, Badawi R, Cherry S, Fontaine K, He L, Henry S, et al.
J Nucl Med
. 2024 Jun;
65(8):1320-1326.
PMID: 38871391
The collaboration of Yale, the University of California, Davis, and United Imaging Healthcare has successfully developed the NeuroEXPLORER, a dedicated human brain PET imager with high spatial resolution, high sensitivity,...
8.
Cayir S, Zhornitsky S, Barzegary A, Sotomayor-Carreno E, Sarfo-Ansah W, Funaro M, et al.
Neurosci Biobehav Rev
. 2024 May;
162():105713.
PMID: 38733895
The kappa opioid receptor (KOR) system is implicated in dysphoria and as an "anti-reward system" during withdrawal from opioids. However, no clear consensus has been made in the field, as...
9.
Cayir S, Volpi T, Toyonaga T, Gallezot J, Yang Y, Sadabad F, et al.
J Neuroimaging
. 2024 Apr;
34(5):627-634.
PMID: 38676301
Background And Purpose: Frontotemporal dementia (FTD) is a clinically and pathologically heterogeneous neurodegenerative condition with a prevalence comparable to Alzheimer's disease for patients under 65 years of age. Limited studies...
10.
Ibrahim W, An J, Yang Y, Cosgrove K, Matuskey D
Neurosci Lett
. 2024 Apr;
828:137766.
PMID: 38583505
Introduction: The neuroimmune system performs a wide range of functions in the brain and the central nervous system. The microglial translocator protein (TSPO) has an established role as a cell...